Unveiling a Biomarker Signature of Meningioma: The Need for a Panel of Genomic, Epigenetic, Proteomic, and RNA Biomarkers to Advance Diagnosis and Prognosis

Unveiling a Biomarker Signature of Meningioma: The Need for a Panel of Genomic, Epigenetic, Proteomic, and RNA Biomarkers to Advance Diagnosis and Prognosis

<p dir="ltr">Meningiomas are the most prevalent primary intracranial tumors. The majority are benign but can undergo dedifferentiation into advanced grades classified by World Health Organization (WHO) into Grades 1 to 3. Meningiomas’ tremendous variability in tumor behavior and slow...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلف الرئيسي: Reem Halabi (22482097) (author)
مؤلفون آخرون: Fatima Dakroub (13014998) (author), Mohammad Z. Haider (5429717) (author), Stuti Patel (3899836) (author), Nayef A. Amhaz (22482098) (author), Mohammad A. Reslan (22482102) (author), Ali H. Eid (5461829) (author), Yehia Mechref (17849097) (author), Nadine Darwiche (12223496) (author), Firas Kobeissy (17849094) (author), Ibrahim Omeis (11496641) (author), Abdullah Shaito (20545181) (author)
منشور في: 2023
الموضوعات:
Biological sciences
Biochemistry and cell biology
Genetics
Biomedical and clinical sciences
Medical biochemistry and metabolomics
Neurosciences
Oncology and carcinogenesis
meningioma
NF2 mutations
biomarker
miRNA
proteomics
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة

مواد مشابهة